REGISTRATION RIGHTS AGREEMENTRegistration Rights Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus
This Registration Rights Agreement (this “Agreement”) is made and entered into as of February 6, 2013, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each of the several purchasers signatory hereto (each such purchaser, a “Purchaser” and, collectively, the “Purchasers”).
SECURITIES PURCHASE AGREEMENTSecurities Purchase Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This Securities Purchase Agreement (this “Agreement”) is dated as of February 6, 2013, between BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each purchaser identified on the signature pages hereto (each, including its successors and assigns, a “Purchaser” and collectively, the “Purchasers”).
CONSULTING AGREEMENTConsulting Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • California
This Consulting Agreement (this “Agreement”) is made and entered into as of April 1, 2013 (the “Effective Date”) by and between BioSig Technologies, Inc., a Delaware corporation with its principal place of business at 12424 Wilshire Boulevard, Suite 745, Los Angeles, California 90025 (the “Company”), and Vivek Reddy, with a principal place of business at Mount Sinai School of Medicine, Department of Medicine, Division of Cardiology, One Gustave L. Levy Place, New York, NY 10029 (“Consultant”) (each herein referred to individually as a “Party,” or collectively as the “Parties”).
SECURITIES PURCHASE AGREEMENT Dated as of December 27, 2011 of BIOSIG TECHNOLOGIES, INC.Securities Purchase Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
This SECURITIES PURCHASE AGREEMENT (this “Agreement”) is dated as of November 28, 2011 by and among BioSig Technologies, Inc., a Delaware corporation (the “Company”), and each of the purchasers identified on Schedule I hereto (individually, a “Purchaser” and collectively, the “Purchasers”).
CONSULTING AGREEMENTConsulting Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • Delaware
This consulting agreement (the “Agreement”), made as of March 30, 2012 is entered into by BioSig Technologies, Inc., at 12424 Wilshire Blvd Suite 745, Los Angeles, CA 90025 (the “Company”), and, Dr. Mauricio S. Arruda at 4030 Oxford Court, Orange Village, 44122 – Ohio (the “Consultant”).
SECURITIES PURCHASE AGREEMENT Dated as of September 19, 2011 of BIOSIG TECHNOLOGIES, INC.Securities Purchase Agreement • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus • New York
THIS SECURITIES PURCHASE AGREEMENT (THE “AGREEMENT”) WAS PREPARED SOLELY BY BIOSIG TECHNOLOGIES, INC. (THE “COMPANY”) TO PROVIDE TO POTENTIAL PURCHASERS OF THE SECURITIES OFFERED HEREBY.
FORM OF NOTEConvertible Promissory Note • September 11th, 2013 • BioSig Technologies, Inc. • Electromedical & electrotherapeutic apparatus
THIS NOTE HAS NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “ACT”), OR APPLICABLE STATE SECURITIES LAWS, AND MAY NOT BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE ABSENCE OF SUCH REGISTRATION OR RECEIPT BY THE COMPANY OF AN OPINION OF COUNSEL IN THE FORM, SUBSTANCE AND SCOPE REASONABLY SATISFACTORY TO THE COMPANY THAT THIS NOTE MAY BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF, UNDER AN EXEMPTION FROM REGISTRATION UNDER THE ACT AND SUCH STATE SECURITIES LAWS.
